Zhou NY, Lin YX, Chen LX, Ye LS, Hu B. Refining the targeted population and achieving better for colorectal cancer screening. World J Gastroenterol 2024; 30(25): 3140-3142 [PMID: 39006381 DOI: 10.3748/wjg.v30.i25.3140]
Corresponding Author of This Article
Bing Hu, MD, Professor, Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, China. hubing@wchscu.edu.cn
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jul 7, 2024; 30(25): 3140-3142 Published online Jul 7, 2024. doi: 10.3748/wjg.v30.i25.3140
Refining the targeted population and achieving better for colorectal cancer screening
Nuo-Ya Zhou, Yi-Xiu Lin, Liu-Xiang Chen, Lian-Song Ye, Bing Hu
Nuo-Ya Zhou, Yi-Xiu Lin, Liu-Xiang Chen, Lian-Song Ye, Bing Hu, Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Author contributions: Zhou NY and Lin LX drafted the manuscript; Chen LX, Ye LS, and Hu B revised the manuscript; and all authors have read and approved the final manuscript.
Supported bythe National Natural Science Foundation of China, No. 82170675; and 135 Project for Disciplines of Excellence, West China Hospital, Sichuan University, No. ZYJC21011.
Conflict-of-interest statement: All authors have no conflict of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bing Hu, MD, Professor, Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, China. hubing@wchscu.edu.cn
Received: March 13, 2024 Revised: May 11, 2024 Accepted: June 7, 2024 Published online: July 7, 2024 Processing time: 109 Days and 19.3 Hours
Abstract
This editorial comments on the article entitled “Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?” by Agatsuma et al, who conducted a retrospective study aiming at clarifying the stage at colorectal cancer (CRC) diagnosis based on different diagnostic routes. We share our opinion about CRC screening programs. The current situation suggests the need for a more specific and targeted population for CRC screening.
Core Tip: We comment on a retrospective study by Agatsuma et al on the early-stage detection of colorectal cancer (CRC) in three groups based on different diagnostic routes. We share our opinion about this study and further discuss the current status of CRC screening in different countries and regions. We believe that a more specific and targeted population is necessary for the better implementation of CRC screening.
